NJIT News Room

Looking for something?
Search Newsroom
RSS Feed
Contact Information: Tanya Klein Public Relations 973-596-3433

Urovalve Appoints European Managing Director

Urovalve, a medical device company located in the Enterprise Development Center at NJIT, has appointed Bent Johnsen as European managing director. The company develops superior products for urinary flow and control.

Johnsen has extensive experience working with large and small European medical device companies. Most recently, he was CEO of PNN Medical, a company that specializes in minimally invasive medical devices for urology.  Previously, he was corporate sales and marketing director for Unomedical; partner and managing director for Kunde & Co.; and held positions with Novo Nordisk, including vice president for U.S. marketing and vice president of European sales

“Bent will lead Urovalve's market entry into Europe with the launch of our FolEase™ catheter projected for late-2011, followed by the launch of our Surinate® Bladder Management System projected for early 2012,” said Harvey D. Homan, Ph.D., President and CEO of Urovalve .

Urovalve has developed the patent-pending FolEase™ Catheter with Inserter System that is preassembled with a Foley catheter.  The system is designed to facilitate insertion of a Foley catheter, especially for difficult situations, such as urethral strictures.  FolEase™ is expected to reduce the time required for healthcare professionals to complete insertion of a Foley catheter, reduce the number of instances that require a urologist to be called in to complete an insertion, and be less expensive and simpler to use than other more invasive options that are currently employed.

Urovalve’s flagship product in development is the Surinate® Bladder Management System, designed to eliminate the need for a urine-collection bag or the discomfort and inconvenience of intermittent catheterization. Surinate® is designed with a magnetic valve inside the catheter that allows the bladder to fill and then empty only on manual control by the patient.  The patient uses an external magnet to open the valve in the Surinate® catheter to drain the bladder only when he needs to.  Furthermore, the Surinate® valved catheter is designed to remain in the patient for up to 30 days. Thus, with Surinate® the patient himself has total control over his bladder-emptying process.

Urovalve, Inc. is a privately-held medical devices company that addresses problems associated with urinary flow and control.

NJIT, New Jersey's science and technology university, enrolls approximately 10,000 students pursuing bachelor's, master's and doctoral degrees in 120 programs. The university consists of six colleges: Newark College of Engineering, College of Architecture and Design, College of Science and Liberal Arts, School of Management, College of Computing Sciences and Albert Dorman Honors College. U.S. News & World Report's 2012 Annual Guide to America's Best Colleges ranked NJIT in the top tier of national research universities. NJIT is internationally recognized for being at the edge in knowledge in architecture, applied mathematics, wireless communications and networking, solar physics, advanced engineered particulate materials, nanotechnology, neural engineering and e-learning. Many courses and certificate programs, as well as graduate degrees, are available online through the Division of Continuing Professional Education.